September 2018 - AMDA Pompe

Spark Therapeutics Gene Therapy Research Webinar

Sep 25, 2018 | PAST WEBINARS

Webinar Details Title: Spark Therapeutics Gene Therapy Research Webinar Date: Tuesday, September 25, 2018 Speakers:Federico Mingozzi, PhD – Chief Scientific OfficerPaul Monahan, MD – Translation Medicine Leader, Metabolic DisordersAmy Fisher, MS, CGC...

AMDA Webinar: Spark Therapeutics Gene Therapy Research

Sep 16, 2018 | NEWS

SPARK THERAPEUTICS GENE THERAPY RESEARCH WEBINAR Please join the AMDA for a webinar focused on Spark Therapeutics and gene therapy research Take this opportunity to learn more about Spark as a company and the field of gene therapy research. We will be joined by...

2018 Helen Walker Research Grant For Pompe Disease Now Accepting Applications

Sep 16, 2018 | NEWS

The AMDA is excited to announce a research grant opportunity for applicants who are involved in Pompe Disease research. This grant opportunity was made possible by the 2018 Pull for Pompe, a private fundraiser held by the Precast Manufacturer’s Association of Texas...

Press Release: Amicus Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease

Sep 10, 2018 | NEWS

CRANBURY, N.J., Sept. 10, 2018—Amicus Therapeutics, a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, announced today regulatory and clinical advancements in its development program AT-GAA for...

info@amda-pompe.org

Spark Therapeutics Gene Therapy Research Webinar

AMDA Webinar: Spark Therapeutics Gene Therapy Research

2018 Helen Walker Research Grant For Pompe Disease Now Accepting Applications

Press Release: Amicus Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease

News Archives

Post Categories